Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Achieve Life Science Inc (ACHV)

80 + Investors. Track Smart Money conviction in ACHV. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +3
Streak
3Q ▲
Buyers last Q
51%

Smart Money Signals — ACHV

Based on 80 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added ACHV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
80 hedge funds hold ACHV right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +13% more funds vs a year ago

fund count last 6Q
+9 new funds entered over the past year (+13% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 51% buying

36 buying35 selling
Last quarter: 36 funds bought or added vs 35 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-6 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 18 → 22 → 22 → 16. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
📌

Mixed — 31% long-term, 45% new

■ 31% conviction (2yr+) ■ 24% medium ■ 45% new
Of the 80 current holders: 25 (31%) held >2 years, 19 held 1–2 years, and 36 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares -5%, value -43%

Value
-42%
Shares
-4%
Last quarter: funds added -5% more shares while total portfolio value only changed -43%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~16 new funds/quarter

10 → 18 → 22 → 22 → 16 new funds/Q
New funds entering each quarter: 18 → 22 → 22 → 16. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 40% veterans vs 42% newcomers

■ 40% veterans ■ 18% 1-2yr ■ 42% new
Entry-cohort mix of 85 holders: 34 (40%) are 2+ year veterans, 15 entered 1–2 years ago, and 36 (42%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
21 of 79 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in ACHV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.4
out of 10
Moderate Exit Risk
Exit risk score 4.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ACHV

In 2026 Q1, 36 hedge funds were net buyers of ACHV (16 opened a new position, 20 added to an existing one), while 35 reduced or exited (22 trimmed, 13 sold completely) — a 51% buyer ratio, indicating a slight buying edge. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 40% of total institutional value in ACHV is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +3 funds (more new holders than closures). Total institutional holders: 80.

Hedge Fund Ownership: ACHV

How many hedge funds hold ACHV — quarterly history vs. share price
Quarterly hedge fund ownership of ACHV vs. share price

Market Analysis: ACHV

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ACHV

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Achieve Life Science Inc (ACHV) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ACHV has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 82d ago
ACHV
+65.0%
XLV
+1.9%

ACHV outperformed XLV by +63.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 37d ago
ACHV
-8.3%
XLV
+3.0%

Since the filing became public, ACHV outperformed XLV by -11.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

8 top-rated funds 1 high-conviction
Consensus
4.1
/ 10
breadth
×
Elite
1.0
/ 10
conviction
Hedge Fund Positioning: ACHV
80 + Investors

Track Smart Money conviction in ACHV. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 80 77 3.9%
13F Shares 22M 23M -4.74%
Total Value $66M $116M -42.95%
New Positions 16 22 -6
Increased Positions 18 26 -8
Closed Positions 13 14 -1
Reduced Positions 22 12 +10
Total Calls 5 4 25.0%
Total Puts 1 2 -50.0%
PUT/CALL Ratio 0.2 0.5 Bullish

Statistics: ACHV

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

80 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ACHV. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ACHV holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Propel Bio Management, LLC 7.17% 3,786,425 $11.4M
2 KVP Capital Advisors, LP 1.02% 462,355 $1.4M
3 SLT Holdings LLC 0.27% 133,300 $392K
4 Lakeside Advisors, INC. 0.22% 111,101 $327K
5 Members Wealth LLC 0.08% 30,000 $127K
6 Nantahala Capital Management, LLC 0.07% 648,885 $1.9M
7 Simplify Asset Management Inc. 0.05% 1,184,512 $3.5M
8 Scientech Research LLC 0.05% 21,718 $64K
9 Shay Capital LLC 0.05% 205,114 $603K
10 nVerses Capital, LLC 0.04% 14,195 $42K
11 Manchester Financial Inc 0.04% 66,222 $195K
12 Next Capital Management LLC 0.03% 34,995 $103K
13 683 Capital Management, LLC 0.03% 200,000 $588K
14 Madison Park Capital Advisors, LLC 0.02% 10,000 $29K
15 Alpine Global Management, LLC 0.02% 50,000 $147K
16 SLT Holdings LLC 0.02% 9,500 $28K
17 Diametric Capital, LP 0.01% 18,651 $55K
18 Magnolia Capital Advisors LLC 0.01% 24,100 $71K
19 Keating Financial Advisory Services, Inc. 0.01% 24,911 $73K
20 Windsor Capital Management, LLC 0.01% 10,817 $32K
21 Catalyst Funds Management Pty Ltd 0.01% 18,000 $53K
22 ADAR1 Capital Management, LLC 0.01% 47,800 $141K
23 Goldstone Financial Group, LLC 0.01% 24,163 $71K
24 Axq Capital, LP 0.01% 15,201 $45K
25 Foundations Investment Advisors, LLC 0.00% 133,300 $392K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Achieve Life Science Inc (ACHV)

What does the Smart Money Trend signal show for ACHV?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added ACHV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ACHV?

Slight buying edge — 51% buying: Last quarter: 36 funds bought or added vs 35 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ACHV holders?

Elite ownership — 40% AUM from top-100 funds: 21 of 79 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in ACHV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ACHV?

Mixed — 31% long-term, 45% new: Of the 80 current holders: 25 (31%) held >2 years, 19 held 1–2 years, and 36 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Achieve Life Science Inc (ACHV) following the 2026 Q1 hedge fund 13F filings?

As of today, ACHV has moved -8.3% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.0% for the XLV sector ETF — an outperformance of -11.3%. Since the quarter end (March 31, 2026), ACHV has gained +65.0% vs +1.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →